Range Financial Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,448
Closed -$670K 185
2021
Q4
$670K Buy
4,448
+294
+7% +$39.7K 0.44% 86
2021
Q3
$496K Buy
+4,154
New +$458K 0.36% 99

Other funds holding TNDM

Range Financial Group's TNDM Position: Q1 2022 in Review

Range Financial Group sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 4,448 shares — an estimated $670K sold.

Range Financial Group first reported a position in TNDM in Q3 2021 and held it in 2 quarters. The position peaked at $670K in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Range Financial Group reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Range Financial Group sold 4,448 Tandem Diabetes Care shares in Q1 2022, an estimated $670K.
  • Range Financial Group first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 2 quarters.
  • Range Financial Group's Tandem Diabetes Care position peaked at $670K in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Range Financial Group's 13F filing for Q1 2022, filed 18 May 2022.